Patents by Inventor Jorge Ronco

Jorge Ronco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and compositions for cutaneous immunisation
    Patent number: 8968743
    Abstract: The invention concerns the development of a system to deliver vaccines via cutaneous route. The invention more particularly concerns the use of a device comprising a condensation compartment for epicutaneous vaccination. The invention also concerns protocols for epicutaneous vaccination allowing an efficient immune response to be obtained without any skin treatment. The invention can be implemented in any mammal, preferably in human beings, to induce a therapeutic or preventive immune response against any type of antigen.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: March 3, 2015
    Assignee: DBV Technologies
    Inventors: Jorge Ronco, Sylvie Godefroy, Bertrand Dupont
  • Method and Compositions for Cutaneous Immunisation
    Publication number: 20100310596
    Abstract: The invention concerns the development of a system to deliver vaccines via cutaneous route. The invention more particularly concerns the use of a device comprising a condensation compartment for epicutaneous vaccination. The invention also concerns protocols for epicutaneous vaccination allowing an efficient immune response to be obtained without any skin treatment. The invention can be implemented in any mammal, preferably in human beings, to induce a therapeutic or preventive immune response against any type of antigen.
    Type: Application
    Filed: December 3, 2008
    Publication date: December 9, 2010
    Inventors: Jorge Ronco, Sylvie Godefroy, Bertrand Dupont
  • Patches and uses thereof
    Patent number: 7635488
    Abstract: A patch comprising a support having electrostatic properties is provided wherein a periphery of the support is coated with an adhesive material, and all or part of the non-adhesive surface of the support is covered with at least one biologically active substance in the form of particles that is adhered to the non-adhesive part of the support by electrostatic forces.
    Type: Grant
    Filed: April 26, 2006
    Date of Patent: December 22, 2009
    Assignee: DBV Technologies
    Inventors: Christophe Dupont, Bertrand Dupont, Pierre-Yves Vannerom, Pierre-Henri Benhamou, Jorge Ronco
  • Patches and uses thereof
    Publication number: 20070048361
    Abstract: A patch comprising a support having electrostatic properties is provided wherein a periphery of the support is coated with an adhesive material, and all or part of the non-adhesive surface of the support is covered with at least one biologically active substance in the form of particles that is adhered to the non-adhesive part of the support by electrostatic forces.
    Type: Application
    Filed: April 26, 2006
    Publication date: March 1, 2007
    Applicant: DBV Technologies
    Inventors: Christophe Dupont, Bertrand Dupont, Pierre-Yves Vannerom, Pierre-Henri Benhamou, Jorge Ronco
  • Adjuvant for vaccine composition
    Publication number: 20050002952
    Abstract: An amphipathic compound including a sterol-derived lipophilic grouping bound to a cationic grouping for use as an adjuvant in the delivery of a vaccine composition. In a particular embodiment, the lipophilic grouping is a cholesterol derivative and the cationic grouping is a quaternary ammonium or a protonatable amine. A vaccine composition including one or more antigens with at least one amphipathic compound having a sterol-derived lipophilic grouping bound to a cationic grouping, is also disclosed.
    Type: Application
    Filed: April 29, 2004
    Publication date: January 6, 2005
    Inventors: Jean Haensler, Emmanuelle Trannoy, Jorge Ronco
  • Adjuvant for a vaccine composition
    Patent number: 6780421
    Abstract: An amphipathic compound including a sterol-derived lipophilic grouping bound to a cationic grouping for use as an adjuvant in the delivery of a vaccine composition. In a particular embodiment, the lipophilic grouping is a cholesterol derivative and the cationic grouping is a quaternary ammonium or a protonatable amine. A vaccine composition including one or more antigens with at least one amphipathic compound having a sterol-derived lipophilic grouping bound to a cationic grouping, is also disclosed.
    Type: Grant
    Filed: September 9, 1997
    Date of Patent: August 24, 2004
    Assignee: Aventis Pasteur SA
    Inventors: Jean Haensler, Emmanuelle Trannoy, Jorge Ronco
  • Use of an amphipathic compound for providing an adjuvant to a subunit vaccine
    Patent number: 6472159
    Abstract: The present invention provides a method of inducing an immune response to a subunit antigen in a non-responding subject by administering to the subject a composition comprising the subunit antigen and an amphipathic compound. A preferred antigen is a hepatitis B antigen, and a preferred amphipathic compound is DC-chol.
    Type: Grant
    Filed: April 16, 2001
    Date of Patent: October 29, 2002
    Assignee: Aventis Pasteur S.A.
    Inventors: Anne Darbouret, Florence Brunel, Jorge Ronco